Calprotectin is an abundant neutrophil cytosolic protein released duri
ng neutrophil activation or death. The use of plasma calprotectin conc
entration as a marker of pulmonary inflammation was tested in 31 child
ren with cystic fibrosis, none of whom was acutely unwell or pyrexic.
Twenty three were receiving antibiotics, 21 had positive sputum cultur
es, but none of the traditional tests clearly diagnosed ongoing infect
ion. Plasma calprotectin was significantly higher in the cystic fibros
is group than in matched controls. Sixteen children with cystic fibros
is had values above dthe control range (320-1570 mu g/l). Their chest
radiograph Northern score, an index of accumulated pulmonary involveme
nt, and their plasma copper, an index of acute phase response, both co
rrelated with plasma calprotectin. Plasma gamma-glutamyltransferase al
so correlated weakly with plasma calprotectin: thus, hepatic pathology
may be a confounding variable. However, the data still suggested that
plasma calprotectin is a better index of inflammation than the tradit
ional indices in general use.